Marinus Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hello, everyone. Thank you for joining JPMorgan's Annual Healthcare Conference. I'm Gautham Baliga, Vice President in our Healthcare Investment Banking team. It's my pleasure to welcome Scott Braunstein, CEO of Marinus Pharmaceuticals to present on our platform. Please note that we'll go through some Q&A after Scott goes through the presentation, and you can ask the question by clicking on the Icon ask a question.
With that, I'll hand it over to Scott.
Thanks, Gautham, and thanks for making the time this afternoon. I'll jump right into the presentation and leave plenty of time for Q&A.
Slide 2 of our investor deck is our safe harbor statement, and I'll let you review that on your own.
Slide 3 walks you through a little bit about ganaxolone. Ganaxolone is in is a GABA modulator that has a positive modulatory effects on the GABA receptor, both the synaptic and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |